Aerpio Pharmaceuticals (ARPO) Misses Q2 EPS by 1c

Aerpio Pharmaceuticals (NASDAQ: ARPO) reported Q2 EPS of $0.28, $0.01 worse than the analyst estimate of $0.29. Revenue for the quarter came in at $18.8 million versus the consensus estimate of $18.67 million.

For earnings history and earnings-related data on Aerpio Pharmaceuticals (ARPO) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Pro Diversity Network (IPDN) Reports Q2 Loss of $0.15
• Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c